Recommended protocol for the study of the ex vivo biological effects of virus-inactivated plasma concentrates in patients with von Willebrand disease. The von Willebrand Factor Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis and of the von Willebrand Disease Committee of the World Federation of Hemophilia.
Mannucci
P M
PM
Angelo Bianchi Bonomi Haemophilia and Thrombosis Center, Milan, Italy.
D001760:Bleeding Time; D001803:Blood Transfusion; D002985:Clinical Protocols; D005169:Factor VIII / Q000378:metabolism; D006801:Humans; D010949:Plasma / Q000382:microbiology*; D012107:Research Design / Q000592:standards*; D014766:Viremia / Q000635:transmission; D014842:von Willebrand Diseases / Q000097:blood / Q000628:therapy*
D005169:Factor VIII